CoQ10 to Improve Ejection Fraction in Congestive Heart Failure

Share Button

“Pooled analyses of available randomized controlled trials suggest that CoQ₁₀ may improve the Ejection Fraction in patients with congestive heart failure”

I have chronic atrial fibrillation aka A-Fib. A-Fib is a pretty common side-effect of high dose chemotherapy. I’ve read that I can live a long and happy life (EveryDay Health) if I take care of my heart and avoid congestive heart failure…

The study linked and excerpted below states that Coq10 supplementation (100mg daily) improves ejection fraction. Not to get too technical but since my heart rhythm is way off, blood flow both in and out is also way off. Coq10 keeps the heart muscle strong keeping the ejection fraction up.

Coq10 supplementation is an easy, cost-effective therapy.

  • Coq10 is evidence-based, well-researched therapy for its many health benefits-
  • Doctor’s Best High Absorption Coq10 w/ BioPerine
    has been tested and approved by ConsumerLabs.com–
  • Cost-effective at .15 per 100mg  (lowest cost of ConsumerLab’s evaluation of CoQ10 with bioavailability enhancer)-
  • Doctor’s Best High Absorption Coq10 w/ BioPerine is available through Amazon Prime–(which I use and recommend) BioPerine enhances the absorbability of CoQ10
  • 5% of your Amazon purchase will be donated to PeopleBeatingCancer to support cancer patients with research and education-

I am a cancer survivor and cancer coach. For more information about short, long-term and late stage side effects of aggressive chemotherapy, scroll down the page, post a question or comment and I will reply ASAP.

Thank you,

David Emerson

  • Cancer Survivor
  • Cancer Coach
  • Director PeopleBeatingCancr

Recommended Reading:

Effect of coenzyme Q₁₀ supplementation on heart failure: a meta-analysis.

“The objective of this meta-analysis was to evaluate the impact of CoQ₁₀ supplementation on the ejection fraction (EF) and New York Heart Association (NYHA) functional classification in patients with CHF…

Supplementation with CoQ₁₀ resulted in a pooled mean net change of 3.67%  in the EF… Subgroup analyses showed significant improvement in EF for crossover trials, trials with treatment duration ≤12 wk in length, studies published before 1994, and studies with a dose ≤100 mg CoQ₁₀/d and in patients with less severe CHF. These subgroup analyses should be interpreted cautiously because of the small number of studies and patients included in each subgroup…

CONCLUSIONS: Pooled analyses of available randomized controlled trials suggest that CoQ₁₀ may improve the EF in patients with CHF. Additional well-designed studies that include more diverse populations are needed.”

Leave a Comment:

Add Your Reply